Viking Therapeutics, Inc. · NASDAQ:VKTX
Kelly-Gemmell Dorothy Elizabeth received 6,333 Viking Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 1, 2026 · Filed Aug 7, 2026
On Aug 1, 2026, Kelly-Gemmell Dorothy Elizabeth (Director) received 6,333 Viking Therapeutics, Inc. shares as an award, leaving 6,333 shares. Filed Aug 7, 2026 (Form 4).
- Awarded
- 6,333 shares
- Holding after
- 6,333 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 1, 2026 | Common Stock, par value $0.00001 per share | Award | 6,333 | 6,333 | Direct |
Source
Related
- Viking Therapeutics, Inc.
- Kelly-Gemmell Dorothy Elizabeth
- Viking Therapeutics, Inc. shareholders
- Form 4 · Lian Brian · Jul 29, 2026
- Form 4 · Zante Greg · Jul 29, 2026
- Form 4 · Mancini Marianna · Jul 29, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026